Award Title | Agency | Phase | Award amount | Start Date | End Date |
---|---|---|---|---|---|
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile ...
Circumvent Pharmaceuticals, Inc. Principal Investigator |
HHS | 1 | $199K | 03/01/17 | 11/30/17 |